Posted in | News | Solar Energy

SunEdison Closes on Construction Financing for Regulus Solar Power Plant

SunEdison, a leading solar technology manufacturer and provider of solar energy services announced today that it has closed on construction financing underwritten by Deutsche Bank Securities Inc.

The funds will be used to construct the 60 MW (megawatt) AC (alternating  current) Regulus solar power plant located in Kern County.

SunEdison is managing the construction of the plant, which is planned to be operational by the end of 2014. Regulus will be composed of approximately 250,000 SunEdison Silvantis™ Photovoltaic Solar Modules.  Silvantis Modules are built using SunEdison polysilicon and wafers to ensure maximum reliability and performance.  Once operational SunEdison will provide solar asset management services and 24/7 global monitoring, field dispatch and reporting services through its Renewable Operation Center (ROC).

"Regulus is our largest North America project to date and is evidence of the momentum we are building in the California utility scale solar market," said Bob Powell, SunEdison president of North America.  "In the past month we've announced completion on the Adobe and Cascade projects which total nearly 40 MW AC.  We look forward to participating in the continued growth of the California solar market."

According to the U.S. Environmental Protection Agency Greenhouse Gas Equivalencies Calculator, the two plants will offset the CO2 emissions of over 100 million pounds of coal annually.  The plant is designed to generate enough electricity to power over 10,000 homes per year.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.